A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
about
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionPD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceHigh sensitivity of cancer exome-based CD8 T cell neo-antigen identificationDevelopment of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.Cancer immunotherapy targeting neoantigens.Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.Molecular aspects of renal cell carcinoma: a review.HLA-binding properties of tumor neoepitopes in humans.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells.Association of the autoimmune disease scleroderma with an immunologic response to cancer.In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Immunotherapy for renal cell carcinoma
P2860
Q22010943-B5E3B507-2471-4BB6-813F-3A999B20A8C6Q26865789-943B8F3C-C148-4FDA-9311-B32B0954DF49Q33930588-CC2583CA-8A24-445D-B5DC-16ADF12973F1Q34700939-AA6B1483-C50F-4840-A209-0637BE54C066Q36316627-630C8552-D0FE-44DC-9AE8-E4C13E8E2C32Q36889067-5D584566-5DDC-4C36-89BC-1BB4B873E0CFQ36972782-D74227BD-A690-4145-B222-1493D67B8F19Q37942072-11FC9FFA-078B-482D-B814-3BAE57997C00Q38217357-77598D47-FDC7-43F7-879E-FAC8BEC92A22Q39057617-5A3FDD6B-D6DE-4D4A-9F25-C73618383E98Q39144502-80011BF2-3153-4247-8E45-CC8A63C7DA2DQ39301397-20742975-087B-4575-A948-947AC80FB961Q40043509-95799200-428B-450A-8796-574FFCD0578EQ41771171-379BD5B9-DAC6-4979-B8F5-47D489339F10Q49432766-5EBF482E-8052-4573-A6E8-84AB429D97DCQ58652034-2DBB9283-7220-444C-8631-24E82B51DAC2
P2860
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@ast
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@en
type
label
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@ast
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@en
prefLabel
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@ast
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
@en
P2093
P1476
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma
@en
P2093
P304
P407
P577
1999-02-01T00:00:00Z